Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
A separate strategic bet is Rebyota the first FDA-approved live biotherapeutic product for recurrent Clostridioides difficile infection marking Ferring's entry into the microbiome therapy space and diversifying its peptide-centric portfolio
A third body is clinical, spanning the diabetes and obesity trial programs reported from 2018 onward
IV Therapy is an advanced wellness treatment that delivers high-quality vitamins, minerals, antioxidants, and electrolytes directly into your bloodstream through an intravenous drip
Placebo-controlled superiority trials in type 2 diabetes (T2D) LEADER, SUSTAIN-6, REWIND, and SOUL and in obesity without diabetes (SELECT) demonstrated statistically significant reductions in major adverse cardiovascular events (MACE) of approximately 12%26% [3], [4], [10][12]
)
US$ 27.17
US$ 28.28
US$ 26.63
